abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update
MarketBeat
abrdn Life Sciences Investors (NYSE:HQL - Get Free Report) was the target of a significant decline in short interest in the month of June. As of June 30th, there was short interest totaling 14,265 shares, a decline of 60.1% from the June 15th total of 35,781 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily volume of 150,344 shares, the short-interest ratio is currently 0.1 days.
NYSE:HQL